Overview

Overview

Boston Scientific's Cardiac Rhythm Management (CRM) Group is a leading developer of implantable devices used to treat cardiac arrhythmias (abnormal heart rhythms), sudden cardiac arrest, and heart failure.

Boston Scientific is a company on the forefront of Cardiac Rhythm Management therapy. Our CRM group works in concert with our Electrophysiology group to offer state-of-the-art products to treat a number of cardiac conditions.

Electrophysiology Group

The Electrophysiology group focuses on treating rapid arrhythmias with solutions that are often preferable to long-term drug therapy or surgeries-solutions such as less-invasive procedures.

Products used in the less-invasive treatment for arrhythmias include the following:

Diagnostic cardiac catheters accurately map the heart's electrical signals. These catheters allow an electrophysiologist to identify the site where an arrhythmia is originating.

Ablation catheters use radiofrequency (RF) energy to render the heart's abnormal sites electrically inactive. This procedure treats the arrhythmia and restores a normal heart rate.

CRM Group

The CRM group focuses on developing the most advanced implantable devices to help treat a number of cardiac conditions.

Pacemakers treat people with bradyarrhythmias, or slow heart rhythms. Pacemakers can help relieve symptoms such as fatigue.

Implantable cardioverter defibrillators (ICDs) treat tachyarrhythmias, or fast heart rhythms. Tachyarrhythmias in the ventricles can be life threatening. So ICDs can not only stop a fast rhythm and restore a normal heart rate, they can also help prevent sudden cardiac death.

Cardiac resynchronization therapy (CRT) devices help resynchronize the ventricles-allowing both sides of the heart to beat in a coordinated way. CRT devices can relieve patients' symptoms of heart failure such as fatigue and shortness of breath.

The Boston Scientific CRM group has a distinguished track record. The CRM group not only introduced the world's first ICD, it also pioneered the research that led to CRT devices.

Today we continue this proud tradition of innovation. We remain committed to developing ever-improving technology. And in that way we secure Boston Scientific's role as a leader in the industry.